Download
1 / 7
0 likes | 3 Views
The journey of a new drug from the laboratory to market is a long and complex process. It requires rigorous testing, regulatory oversight, and a clear understanding of the clinical drug development phases to ensure that the drug is safe and effective for public use<br>Explore:- https://clival.com/drug-development
E N D
The journey of a new drug from the laboratory to market is a long and complex process. It requires rigorous testing, regulatory oversight, and a clear understanding of the clinical drug development phasesto ensure that the drug is safe and effective for public use Introduction
Drug Discovery and Preclinical Testing • Phase 1: Clinical Trials - Safety Testing • Phase 2: Clinical Trials - Efficacy and Side Effects • Phase 3: Clinical Trials - Large-Scale Testing and Final Approval • Phase 4: Post-Marketing Surveillance Understanding the Drug Development Process
Clinical trial data: Ensuring that all trials are conducted according to the latest scientific protocols and regulations. • Market trends and patient demographics: Understanding the demand for new treatments and assessing market potential for new drugs. • Regulatory compliance: Navigating the complex regulatory environment to ensure the drug passes all necessary legal and health safety standards. Importance of Data Providers in Clinical Drug Development
After successfully completing all the phases of clinical drug development, the next step in the drug development process phases is submitting the data to regulatory authorities. In the United States, this is done through the New Drug Application (NDA) process, where the pharmaceutical company submits all clinical trial data, manufacturing information, and evidence of the drug's safety and efficacy. Path to Drug Approval
Website www.clival.com Location:- C-89, Sector-65 Noida-U.P. 201301 (India) E-Mail:- info@lifescienceintellipedia.com | sales@lifescienceintellipedia.com Phone:- +91-120-6631301-335 Mob No:- +91-9990237670
